NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Internap Corporation (NASDAQ: INAP ), Approach Resources Inc. (NASDAQ: AREX ), Agile Therapeutics, Inc. (NASDAQ: AGRX ), Town Sports International Holdings, Inc. (NASDAQ: CLUB ), Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA ), and Cott Corporation (NYSE: COT ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
INAP DOWNLOAD: http://Fundamental-Markets.com/register/?so=INAP AREX DOWNLOAD: http://Fundamental-Markets.com/register/?so=AREX AGRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=AGRX CLUB DOWNLOAD: http://Fundamental-Markets.com/register/?so=CLUB DRNA DOWNLOAD: http://Fundamental-Markets.com/register/?so=DRNA COT DOWNLOAD: http://Fundamental-Markets.com/register/?so=COT
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Internap Corporation (NASDAQ: INAP ), Approach Resources Inc. (NASDAQ: AREX ), Agile Therapeutics, Inc. (NASDAQ: AGRX ), Town Sports International Holdings, Inc. (NASDAQ: CLUB ), Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA ), and Cott Corporation (NYSE: COT ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
Internap Corporation (INAP) REPORT OVERVIEW
Internap's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Internap reported revenue of $81.96MM vs $69.64MM (up 17.69%) and basic earnings per share -$0.69 vs -$0.96. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Internap reported revenue of $280.72MM vs $298.30MM (down 5.89%) and basic earnings per share -$2.39 vs -$9.54. Internap is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.56. The estimated EPS forecast for the next fiscal year is -$1.66 and is expected to report on March 14th, 2019.
To read the full Internap Corporation (INAP) report, download it here: http://Fundamental-Markets.com/register/?so=INAP
-----------------------------------------
Approach Resources Inc. (AREX) REPORT OVERVIEW
Approach Resources' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Approach Resources reported revenue of $30.33MM vs $24.97MM (up 21.45%) and basic earnings per share -$0.10 vs -$0.10. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Approach Resources reported revenue of $105.35MM vs $90.30MM (up 16.66%) and basic earnings per share -$1.35 vs -$1.26. Approach Resources is expected to report earnings on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.08. The estimated EPS forecast for the next fiscal year is -$0.21 and is expected to report on March 14th, 2019.
To read the full Approach Resources Inc. (AREX) report, download it here: http://Fundamental-Markets.com/register/?so=AREX
-----------------------------------------
Agile Therapeutics, Inc. (AGRX) REPORT OVERVIEW
Agile Therapeutics' Recent Financial Performance
Agile Therapeutics is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast for the next fiscal year is -$0.70 and is expected to report on March 11th, 2019.
To read the full Agile Therapeutics, Inc. (AGRX) report, download it here: http://Fundamental-Markets.com/register/?so=AGRX
-----------------------------------------
Town Sports International Holdings, Inc. (CLUB) REPORT OVERVIEW
Town Sports International's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Town Sports International reported revenue of $112.33MM vs $99.99MM (up 12.34%) and basic earnings per share $0.02 vs -$0.02. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Town Sports International reported revenue of $403.04MM vs $396.92MM (up 1.54%) and basic earnings per share $0.16 vs $0.31 (down 48.39%). Town Sports International is expected to report earnings on October 25th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.34. The estimated EPS forecast for the next fiscal year is $0.29 and is expected to report on February 27th, 2019.
To read the full Town Sports International Holdings, Inc. (CLUB) report, download it here: http://Fundamental-Markets.com/register/?so=CLUB
-----------------------------------------
Dicerna Pharmaceuticals, Inc. (DRNA) REPORT OVERVIEW
Dicerna Pharmaceuticals' Recent Financial Performance
For the twelve months ended December 31st, 2017 vs December 31st, 2016, Dicerna Pharmaceuticals reported revenue of $2.28MM vs $0.30MM (up 671.86%) and basic earnings per share -$3.66 vs -$2.87. Dicerna Pharmaceuticals is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.92. The estimated EPS forecast for the next fiscal year is -$1.10 and is expected to report on March 14th, 2019.
To read the full Dicerna Pharmaceuticals, Inc. (DRNA) report, download it here: http://Fundamental-Markets.com/register/?so=DRNA
-----------------------------------------
Cott Corporation (COT) REPORT OVERVIEW
Cott's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Cott reported revenue of $603.60MM vs $580.60MM (up 3.96%) and basic earnings per share $0.08 vs -$0.18. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cott reported revenue of $2,269.70MM vs $1,623.20MM (up 39.83%) and basic earnings per share -$0.01 vs -$0.61. Cott is expected to report earnings on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.06. The estimated EPS forecast for the next fiscal year is $0.39 and is expected to report on March 7th, 2019.
To read the full Cott Corporation (COT) report, download it here: http://Fundamental-Markets.com/register/?so=COT
-----------------------------------------
ABOUT Fundamental Markets
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
